COVID-19 Update: Further decline in new deaths puts reopening plans on track, stock markets edge higher

The bottom line is that the global number of new deaths is moving lower, with the same trend seen in all regions. The growth rate for deaths is now 1-2% across Europe and the US. The trial results for the drug Kevzara disappointed, although it did have a small positive effect on critical cases.

Read the full article on Danske Bank Research's website.

Want to get in touch?